4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-025029
Chief Technology Officer sold 20,000 shares at $9.71 ($194,200)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Yan Ming Chief Technology Officer | 2023-04-19 | Sale 10b5-1 | −20,000 | $9.71 | $194,200 | 7,886,053 | D |
| Open-market sales · 20,000 sh · avg $9.71 · $194,200 | |||||||
Loading xslF345X04/doc4.xml…